Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis

Ophthalmic Surgery and Lasers

Volumn 28, Issue 3, 1997, Pages 185-194

  Essman, Thomas F ^a   Flynn Jr , Harry W ^a   Smiddy, William E ^a   Brod, Roy D ^b   Murray, Timothy G ^a   Davis, Janet L ^a   Rubsamen, Patrick E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; DEXAMETHASONE; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE;

ADULT; AGED; ARTICLE; ASPERGILLOSIS; CANDIDIASIS; CATHETER INFECTION; CLINICAL ARTICLE; ENDOPHTHALMITIS; FEMALE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VITRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 0030900632     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Brod RD, Clarkson JG, Flynn HW Jr, Green RW. Endogenous fungal endophthalmitis. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology, vol. 3. Philadelphia: J. B. Lippincott; 1990:1-30.
2. Brod RD, Flynn HW Jr, Clarkson JG, et al. Endogenous Candida endophthalmitis: management without intravenous Amphotericin B. Ophthalmology. 1990;97:666-674.
3. Edwards JE Jr, Foos RY, Montgomerie JZ, Guze LB. Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine. 1974;53:47-75.
4. Aguilar GL, Blumenkranz MS, Egbert PR, McCulley JP. Candida endophthalmitis after intravenous drug abuse. Arch Ophthalmol. 1979;97:96-99.
5. Kostick DA, Foster RE, Lowder CY, Meyers SM, McHenry MC. Endogenous endophthalmitis caused by Candida albicans in a healthy woman. Am J Ophthalmol. 1992;113:593-595. Letter.
6. Valluri S, Moorthy RS, Liggett PE, Rao NA. Endogenous Aspergillus endophthalmitis in an immunocompetent individual. Int Ophthalmol. 1993;17:131-135.
7. Okada AA, Johnson RP, Liles WC, D'Amico DJ, Baker AS. Endogenous bacterial endophthalmitis: report of a ten-year retrospective study. Ophthalmology. 1994; 101:832-838.
8. Parke DW II, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982;89:789-796.
9. Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med. 1989;149:2226-2228.
10. Bross J, Talbot GH, Maislin G, et al. Risk factors for nosocomial candidemia: a case control study in patients without leukemia. Am J Med. 1989; 87:614-620.
11. Donahue SP, Greven CM, Zuravleff JJ, et al. Intraocular candidiasis in patients with candidemia: clinical implications derived from a prospective multicenter study. Ophthalmology. 1994;101:1302-1309.
12. Menezes AV, Sigesmund DA, Demajo WA, Devenyi RG. Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med. 1994;154: 2093-2097.
13. Klein JJ, Watanakunakorn C. Hospital-acquired fungemia: its natural course and significance. Am J Med. 1979;67:51-67.
14. Streilein JW, Wilbanks GA, Cousins SW. Immunoregulatory mechanisms of the eye. J Neuroimmunol. 1992;39:185-200.
15. Barrie T. The place of elective vitrectomy in the management of patients with Candida endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 1987;225:107-113.
16. Borne MJ, Elliot JH, O'Day DM. Ocular fluconazole treatment of Candida parapsilosis endophthalmitis after failed intravitreal amphotericin B. Arch Ophthalmol. 1993;111:1326-1327. Letter.
17. Urbak SF, Degn T. Fluconazole in the treatment of Candida albicans endophthalmitis. Acta Ophthalmol. 1992;70:528-529.
18. Laatikainen L, Tuominen M, von Dickhoff K. Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy. Am J Ophthalmol. 1992;113:205-207. Letter.
19. Guex-Crosier Y, Chave JP, Herbert CP. Postpartum Candida endophthalmitis treated with fluconazole. Ophthalmologica. 1993;206:214-215.
20. Luttrull JK, Wan WL, Kubak BM, Smith MD, Oster HA. Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol. 1995;119:477-481.
21. Aider ME, Vellend H, McNeely DM, Walmsley SL, Gold WL. Use of fluconazole in the treatment of Candida endophthalmitis. Clin Infect Dis. 1995; 20:657-664.
22. O'Day DM, Foulds G, Williams TE, et al. Ocular uptake of fluconazole following oral administration. Arch Ophthalmol. 1990;108:1006-1008.
23. Isobe Y, Hatano H. Study of suppressive effect of intravenous fluconazole on endogenous Candida endophthalmitis in rabbits. Jpn J Ophthalmol. 1992;36:23-27.
24. Axelrod AJ, Peyman GA, Apple DJ. Toxicity of intravitreal injection of amphotericin B. Am J Ophthalmol. 1973;76:578-583.
25. Souri EN, Green WR. Intravitreal amphotericin B toxicity. Am J Ophthalmol. 1974;78:77-81.
26. Stern GA, Fetkenhour CL, O' Grady RB. Intravitreal amphotericin B treatment of Candida endophthalmitis. Arch Ophthalmol. 1977;95:89-93.
27. Kroll P, Emmerich KH, Fegeler W. Candida albicans endophthalmitis: ergebnisse der pars plana-vitrektomie ohne intraokulare antimykotische therapie. Klin Monatsbl Augenheilkd. 1984;184:104-108.
28. Schulman JA, Peyman GA. Intravitreal corticosteroids as an adjunct in the treatment of bacterial and fungal endophthalmitis. Retina. 1992;12:336-340.
29. Coats ML, Peyman GA. Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis. Retina. 1992;12:46-51.
30. Pflugfelder SC, Flynn HW Jr, Zwickey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology. 1988;95:19-30.